Research Information System
Bozok Veterinary Science, vol.3, no.1, pp.1-8, 2022 (TRDizin)
Recently,
antibiotic resistance has become an important risk threatening human and animal
health. Multiple antibiotic drug resistance is frequently reported by researchers.
An important topic on antibiotic resistance is Extended Spectrum
Beta-lactamases, and the ESBL group consists of microorganisms that show
multiple drug resistance. ESBL positive bacteria are also present in animals
and can infect humans through food. Therefore, the issue of ESBL is a common
subject of both human and veterinary medicine. ESBL is followed closely by the
scientific world and continues its classification and species analysis studies.
Therefore, the World Health Organization recommends regular follow-up of
microorganisms that develop multiple antibiotic resistance, and ESBL screening
and verification methods can be performed with various analyzes. Antibiotics
containing carbapenems are reported as an important group used in human
medicine, and resistance to carbapenem group antibiotics used against ESBL
positive bacteria is increasing continually. However, antibiotic resistance in
the carbapenem group used against ESBL is life-threatening, especially in
patients in intensive care. Colistin is known as the last resort antibiotic and
used in combination then once again the focus of attention in the scientific
world with these developments. This study aimed to reveal the importance of
ESBL, carbapenems, and colistin antibiotic groups and the resistance developing
against these antibiotic groups.